E Fund Management’s Moderna MRNA Stock Holding History

E Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$876K	Buy	+17,237	New	+$804K	0.03%	203
2025 Q2	$1.35M	Buy	48,865 +10,920	+29%	+$288K	0.06%	138
2025 Q1	$1.08M	Buy	37,945 +7,353	+24%	+$261K	0.05%	161
2024 Q4	$1.27M	Buy	30,592 +7,939	+35%	+$379K	0.06%	134
2024 Q3	$1.51M	Buy	22,653 +9,616	+74%	+$883K	0.08%	105
2024 Q2	$1.55M	Buy	13,037 +2,343	+22%	+$297K	0.09%	96
2024 Q1	$1.14M	Sell	10,694 -1,604	-13%	-$162K	0.07%	105
2023 Q4	$1.22M	Buy	12,298 +3,121	+34%	+$263K	0.08%	80
2023 Q3	$948K	Buy	9,177 +1,396	+18%	+$156K	0.07%	85
2023 Q2	$945K	Buy	7,781 +235	+3%	+$31.3K	0.07%	76
2023 Q1	$1.16M	Buy	7,546 +268	+4%	+$44.2K	0.08%	75
2022 Q4	$1.31M	Sell	7,278 -1,662	-19%	-$272K	0.11%	73
2022 Q3	$1.06M	Buy	8,940 +237	+3%	+$36K	0.1%	86
2022 Q2	$1.24M	Buy	8,703 +1,503	+21%	+$215K	0.11%	78
2022 Q1	$1.24M	Buy	7,200 +1,477	+26%	+$249K	0.04%	76
2021 Q4	$1.45M	Buy	5,723 +519	+10%	+$152K	0.05%	86
2021 Q3	$2M	Buy	+5,204	New	+$1.92M	0.08%	65
2021 Q1	$661K	Buy	+5,046	New	+$731K	0.05%	113

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return